Defining the context of use helps ensuring that biomarker assays are developed, validated and applied in a manner that meets the specific needs and goals of the research or clinical application. It provides a framework for evaluating the assay’s performance and suitability, which can ultimately lead to more reliable and meaningful biomarker data. Based on the context-of-use, our experts not only suggest a suitable platform and assay type but also guide you through the fit-for-purpose validation setup.
learn more
By leveraging the specificity of antigen-antibody interactions, immunoassays enable precise detection of a wide array of biomolecules. Various platforms for ligand binding assays are available at Nuvisan, offering the flexibility to support biomarker projects individually.
learn more
Liquid chromatography-mass spectrometry (LC-MS) is a highly sensitive and specific analytical technique widely used for the analysis of a diverse range of biomarkers. Its ability to separate complex mixtures and identify compounds based on their mass-to-charge ratio makes it an invaluable tool.
learn more
Located alongside our Clinical Pharmacology Unit (CPU), our clinical laboratory is committed to delivering highest-quality data and insights to not only support safety assessments but also pharmacodynamic biomarkers.
Learn more
Nuvisan’s own isochronic library was set up to support your biomarker stability assessment and help save you valuable time during assay validation.
Contact Us
Search